Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

OncoArendi Therapeutics presents new AMCase and CHIT1 dual inhibitors for lung diseases

Sep. 6, 2018

AstraZeneca conducts first-in-human study of AZD-8154 in healthy subjects

Sep. 3, 2018

Unexpected asthma mechanism changes targeting calculus

Aug. 27, 2018

New Rho kinase inhibitors described by Chiesi Farmaceutici

Aug. 21, 2018

Vectura completes pediatric studies with VR-647 for asthma

Aug. 21, 2018

Neutrophil 'ghosts' drive severe asthma

Aug. 17, 2018

Kalydeco approved in U.S. for cystic fibrosis in patients aged 12 to < 24 months

Aug. 16, 2018

Bayer, Haplogen to identify antiviral compounds for COPD exacerbations

Aug. 14, 2018

Discovery of a potent and selective receptor antagonist for the treatment of asthma

Aug. 13, 2018

AstraZeneca discovers JAK1 inhibitors

Aug. 10, 2018